Fertilite Koruyucu Yöntemler

OOCYTE M. Mature oocyte cryopreservation: a guideline. Fertility and sterility. 2013;99(1):37-43.

Cascante SD, Berkeley AS, Licciardi F, McCaffrey C, Grifo JA. Planned oocyte cryopreservation: the state of the ART. Reproductive BioMedicine Online. 2023;47(6):103367.

Tsafrir A, Holzer H, Miron-Shatz T, Eldar-Geva T, Gal M, Ben-Ami I, et al. ‘Why have women not returned to use their frozen oocytes?’: a 5-year follow-up of women after planned oocyte cryopreservation. Reproductive BioMedicine Online. 2021;43(6):1137-45.

Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Human reproduction update. 2017;23(2):139-55.

Chamayou S, Sicali M, Alecci C, Ragolia C, Liprino A, Nibali D, et al. The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing. Journal of Assisted Reproduction and Genetics. 2017;34:479-86.

Forman EJ, Li X, Ferry KM, Scott K, Treff NR, Scott Jr RT. Oocyte vitrification does not increase the risk of embryonic aneuploidy or diminish the implantation potential of blastocysts created after intracytoplasmic sperm injection: a novel, paired randomized controlled trial using DNA fingerprinting. Fertility and sterility. 2012;98(3):644-9.

Goldman R, Racowsky C, Farland L, Munné S, Ribustello L, Fox J. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Human reproduction. 2017;32(4):853-9.

Wnuk K, Świtalski J, Miazga W, Tatara T, Religioni U, Olszewski P, et al. The Usage of Cryopreserved Reproductive Material in Cancer Patients Undergoing Fertility Preservation Procedures. Cancers (Basel). 2023;15(22).

Ter Welle-Butalid ME, Derhaag JG, van Bree BE, Vriens IJH, Goddijn M, Balkenende EME, et al. Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study. Hum Reprod. 2024;39(12):2693-701.

Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update. 2017;23(2):139-55.

Azambuja R, Badalotti M, Okada L, Cortes LS, Hentschke MR, Petracco A. Fertility preservation: a case report of a newborn following 13 years of oocyte cryopreservation. JBRA Assist Reprod. 2023;27(2):328-31.

Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Human reproduction update. 2018;24(1):35-58.

Zaat TR, Kostova EB, Korsen P, Showell MG, Mol F, van Wely M. Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support: a systematic review and meta-analysis. Hum Reprod Update. 2023;29(5):634-54.

Medicine PCotASfR. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertility and Sterility. 2019;112(6):1022-33.

Fraison E, Huberlant S, Labrune E, Cavalieri M, Montagut M, Brugnon F, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Hum Reprod. 2023;38(3):489-502.

Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347-53.

Sönmezer M, Şükür YE, Ateş C, Saçıntı KG, Sönmezer M, Aslan B, et al. Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis. Reproductive BioMedicine Online. 2023;47(6):103337.

Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. New England Journal of Medicine. 2000;342(25):1919-.

Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022-33.

Sonmezer M, Ozkavukcu S, Sukur YE, Kankaya D, Arslan O. First pregnancy and live birth in Turkey following frozen-thawed ovarian tissue transplantation in a patient with acute lymphoblastic leukemia who underwent cord blood transplantation. Journal of Assisted Reproduction and Genetics. 2020;37(8):2033-43.

Donnez J, Dolmans M-M. Transplantation of ovarian tissue. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014;28(8):1188-97.

Oktay KH, Marin L. Comparison of orthotopic and heterotopic autologous ovarian tissue transplantation outcomes. Fertil Steril. 2024;121(1):72-9.

Colmorn LB, Pedersen AT, Larsen EC, Hansen AS, Rosendahl M, Andersen CY, et al. Reproductive and Endocrine Outcomes in a Cohort of Danish Women following Auto-Transplantation of Frozen/Thawed Ovarian Tissue from a Single Center. Cancers (Basel). 2022;14(23).

Oktay K, Marin L, Bedoschi G, Pacheco F, Sugishita Y, Kawahara T, et al. Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data. Fertil Steril. 2022;117(1):181-92.

Oktay K. Evidence for Limiting Ovarian Tissue Harvesting for the Purpose of Transplantation to Women Younger than 40 Years of Ageb. The Journal of Clinical Endocrinology & Metabolism. 2002;87(4):1907-8.

Fadini R, Dal Canto M, Mignini Renzini M, Milani R, Fruscio R, Cantù MG, et al. Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. Journal of Assisted Reproduction and Genetics. 2012;29(8):779-81.

Fadini R, Dal Canto MB, Renzini MM, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reproductive BioMedicine Online. 2009;19(3):343-51.

Dolmans MM, von Wolff M, Poirot C, Diaz-Garcia C, Cacciottola L, Boissel N, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021;115(5):1102-15.

Xie B, Li J, Huang Y, Hang F, Hu Q, Yu J, et al. Assessing the impact of transplant site on ovarian tissue transplantation: a single-arm meta-analysis. Reprod Biol Endocrinol. 2023;21(1):120.

Erden M, Uyanik E, Demeestere I, Oktay KH. Perinatal outcomes of pregnancies following autologous cryopreserved ovarian tissue transplantation: a systematic review with pooled analysis. Am J Obstet Gynecol. 2024;231(5):480-9.

Jadoul P, Guilmain A, Squifflet J, Luyckx M, Votino R, Wyns C, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod. 2017;32(5):1046-54.

Hoekman EJ, Louwe LA, Rooijers M, van der Westerlaken LAJ, Klijn NF, Pilgram GSK, et al. Ovarian tissue cryopreservation: Low usage rates and high live-birth rate after transplantation. Acta Obstet Gynecol Scand. 2020;99(2):213-21.

Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908-14.

Greve T, Clasen-Linde E, Andersen MT, Andersen MK, Sørensen SD, Rosendahl M, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120(22):4311-6.

Jahnukainen K, Tinkanen H, Wikström A, Dunkel L, Saarinen-Pihkala UM, Mäkinen S, et al. Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation. Leukemia. 2013;27(5):1183-5.

Sönmezer M, Şükür YE, Saçıntı KG, Özkavukçu S, Kankaya D, Atabekoğlu CS, et al. Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: a case series. American Journal of Obstetrics and Gynecology. 2024;230(1):79. e1-. e10.

Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. Journal of Clinical Oncology. 2018;36(19):1994-2001.

Leonard RCF, Adamson DJA, Bertelli G, Mansi J, Yellowlees A, Dunlop J, et al. GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial. Ann Oncol. 2017;28(8):1811-6.

Turan V, Bedoschi G, Rodriguez-Wallberg K, Sonmezer M, Pacheco FS, Oktem O, et al. Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods. J Clin Oncol. 2019;37(1):84-6.

Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, et al. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial. J Clin Oncol. 2016;34(22):2568-74.

Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2018;36(19):1981-90.

Preservation TEGGoFF, Anderson RA, Amant F, Braat D, D'Angelo A, Chuva de Sousa Lopes SM, et al. ESHRE guideline: female fertility preservation†. Human Reproduction Open. 2020;2020(4).

Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertility and sterility. 2010;93(3):762-8.

Sonmezer M, Oktay K. Fertility preservation in female patients. Human Reproduction Update. 2004;10(3):251-66.

Wallace WHB, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. International Journal of Radiation Oncology* Biology* Physics. 2005;62(3):738-44.

Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T. Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. Journal of ovarian research. 2014;7:1-10.

Tessier L, McKechnie T, Lee Y, Park LJ, Gangam N, Eskicioglu C. Laparoscopic ovarian transposition prior to pelvic radiation in young women with anorectal malignancies: a systematic review and meta-analysis of prevalence. Colorectal Dis. 2023;25(7):1336-48.

Gabriel DA, Bernard SA, Lambert J, Croom RD. Oophoropexy and the management of Hodgkin's disease: A reevaluation of the risks and benefits. Archives of Surgery. 1986;121(9):1083-5.

Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertility and sterility. 2000;74(4):743-8.

Genovese F, Zambrotta E, Incognito GG, Gulino FA, Di Guardo F, Genovese D, et al. Techniques and endocrine-reproductive outcomes of ovarian transposition prior to pelvic radiotherapy in both gynecologic and non-gynecologic cancers: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2024;165(3):948-58.

Huber D, Simonson C, Fournier I, Dischl-Antonioni I, Pena Rios FJ, Francey I, et al. Utero-ovarian transposition before pelvic radiation in a patient with rectal cancer: a case report and systemic literature review. Front Surg. 2024;11:1336047.

Gilchrist RB, Ho TM, De Vos M, Sanchez F, Romero S, Ledger WL, et al. A fresh start for IVM: capacitating the oocyte for development using pre-IVM. Human Reproduction Update. 2024;30(1):3-25.

Isachenko E, Rahimi G, Isachenko V, Nawroth F. In-vitro maturation of germinal-vesicle oocytes and cryopreservation in metaphase I/II: a possible additional option to preserve fertility during ovarian tissue cryopreservation. Reproductive BioMedicine Online. 2004;8(5):553-7.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, et al. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation. Fertility and sterility. 2019;111(2):357-62.

Sauerbrun-Cutler M-T, Vega M, Keltz M, McGovern PG. In vitro maturation and its role in clinical assisted reproductive technology. Obstetrical & gynecological survey. 2015;70(1):45-57.

Creux H, Monnier P, Son W-Y, Buckett W. Thirteen years’ experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments. Journal of assisted reproduction and genetics. 2018;35:583-92.

Bourg M, Moreau J, Carles M, Cadoret F, Lesourd F, Tournier A, et al. Is in vitro maturation of oocytes retrieved ex vivo from ovarian tissue an effective fertility preservation technique in the presence of organic ovarian cysts? European Journal of Obstetrics & Gynecology and Reproductive Biology. 2023;281:87-91.

Meltem S, Ali G, Şükür YE, Hande T, Ebru A, Betül A, et al. Safety and effectiveness of controlled ovarian stimulation and oocyte retrieval during prepubertal and peripubertal period. J Assist Reprod Genet. 2024;41(10):2823-30.

Sönmezer M, Saçıntı KG, Gülümser Ç, Özkavukçu S, Atabekoğlu C, Şükür YE, et al. Transabdominal ultrasound-guided oocyte retrieval for oocyte cryopreservation using a vaginal probe: a comparison of applicability, effectiveness, and safety with conventional transvaginal approach. J Assist Reprod Genet. 2023;40(2):399-405.

Ombelet W, Van Robays J. Artificial insemination history: hurdles and milestones. Facts, views & vision in ObGyn. 2015;7(2):137.

Miller CM, Duong S, Weaver AL, Zhao Y, Shenoy CC. Outcomes of frozen oocyte donor in vitro fertilization (IVF) cycles using fresh versus frozen sperm. Reproductive Sciences. 2022;29(4):1226-31.

Hallak J, Kolettis PN, Sekhon VS, Thomas AJ, Agarwal A. Sperm cryopreservation in patients with testicular cancer. Urology. 1999;54(5):894-9.

Asseler JD, de Nie I, van Rooij FB, Steensma TD, Mosterd D, Verhoeven MO, et al. Transgender persons' view on previous fertility decision-making and current infertility: a qualitative study. Hum Reprod. 2024;39(9):2032-42.

Riggs DW, Bartholomaeus C. Fertility preservation decision making amongst Australian transgender and non-binary adults. Reprod Health. 2018;15(1):181.

De Roo C, Lierman S, Tilleman K, Peynshaert K, Braeckmans K, Caanen M, et al. Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment. Reprod Biomed Online. 2017;34(6):557-66.

Ghofranian A, Estevez SL, Gellman C, Gounko D, Lee JA, Thornton K, et al. Fertility treatment outcomes in transgender men with a history of testosterone therapy. F S Rep. 2023;4(4):367-74.

Mattelin E, Strandell A, Bryman I. Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013–2018. Human reproduction open. 2022;2022(2):hoac008.

OOCYTE M. Mature oocyte cryopreservation: a guideline. Fertility and sterility. 2013;99(1):37-43.

Cascante SD, Berkeley AS, Licciardi F, McCaffrey C, Grifo JA. Planned oocyte cryopreservation: the state of the ART. Reproductive BioMedicine Online. 2023;47(6):103367.

Tsafrir A, Holzer H, Miron-Shatz T, Eldar-Geva T, Gal M, Ben-Ami I, et al. ‘Why have women not returned to use their frozen oocytes?’: a 5-year follow-up of women after planned oocyte cryopreservation. Reproductive BioMedicine Online. 2021;43(6):1137-45.

Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Human reproduction update. 2017;23(2):139-55.

Chamayou S, Sicali M, Alecci C, Ragolia C, Liprino A, Nibali D, et al. The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing. Journal of Assisted Reproduction and Genetics. 2017;34:479-86.

Forman EJ, Li X, Ferry KM, Scott K, Treff NR, Scott Jr RT. Oocyte vitrification does not increase the risk of embryonic aneuploidy or diminish the implantation potential of blastocysts created after intracytoplasmic sperm injection: a novel, paired randomized controlled trial using DNA fingerprinting. Fertility and sterility. 2012;98(3):644-9.

Goldman R, Racowsky C, Farland L, Munné S, Ribustello L, Fox J. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Human reproduction. 2017;32(4):853-9.

Wnuk K, Świtalski J, Miazga W, Tatara T, Religioni U, Olszewski P, et al. The Usage of Cryopreserved Reproductive Material in Cancer Patients Undergoing Fertility Preservation Procedures. Cancers (Basel). 2023;15(22).

Ter Welle-Butalid ME, Derhaag JG, van Bree BE, Vriens IJH, Goddijn M, Balkenende EME, et al. Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study. Hum Reprod. 2024;39(12):2693-701.

Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update. 2017;23(2):139-55.

Azambuja R, Badalotti M, Okada L, Cortes LS, Hentschke MR, Petracco A. Fertility preservation: a case report of a newborn following 13 years of oocyte cryopreservation. JBRA Assist Reprod. 2023;27(2):328-31.

Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Human reproduction update. 2018;24(1):35-58.

Zaat TR, Kostova EB, Korsen P, Showell MG, Mol F, van Wely M. Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support: a systematic review and meta-analysis. Hum Reprod Update. 2023;29(5):634-54.

Medicine PCotASfR. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertility and Sterility. 2019;112(6):1022-33.

Fraison E, Huberlant S, Labrune E, Cavalieri M, Montagut M, Brugnon F, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Hum Reprod. 2023;38(3):489-502.

Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347-53.

Sönmezer M, Şükür YE, Ateş C, Saçıntı KG, Sönmezer M, Aslan B, et al. Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis. Reproductive BioMedicine Online. 2023;47(6):103337.

Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. New England Journal of Medicine. 2000;342(25):1919-.

Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022-33.

Sonmezer M, Ozkavukcu S, Sukur YE, Kankaya D, Arslan O. First pregnancy and live birth in Turkey following frozen-thawed ovarian tissue transplantation in a patient with acute lymphoblastic leukemia who underwent cord blood transplantation. Journal of Assisted Reproduction and Genetics. 2020;37(8):2033-43.

Donnez J, Dolmans M-M. Transplantation of ovarian tissue. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014;28(8):1188-97.

Oktay KH, Marin L. Comparison of orthotopic and heterotopic autologous ovarian tissue transplantation outcomes. Fertil Steril. 2024;121(1):72-9.

Colmorn LB, Pedersen AT, Larsen EC, Hansen AS, Rosendahl M, Andersen CY, et al. Reproductive and Endocrine Outcomes in a Cohort of Danish Women following Auto-Transplantation of Frozen/Thawed Ovarian Tissue from a Single Center. Cancers (Basel). 2022;14(23).

Oktay K, Marin L, Bedoschi G, Pacheco F, Sugishita Y, Kawahara T, et al. Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data. Fertil Steril. 2022;117(1):181-92.

Oktay K. Evidence for Limiting Ovarian Tissue Harvesting for the Purpose of Transplantation to Women Younger than 40 Years of Ageb. The Journal of Clinical Endocrinology & Metabolism. 2002;87(4):1907-8.

Fadini R, Dal Canto M, Mignini Renzini M, Milani R, Fruscio R, Cantù MG, et al. Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. Journal of Assisted Reproduction and Genetics. 2012;29(8):779-81.

Fadini R, Dal Canto MB, Renzini MM, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reproductive BioMedicine Online. 2009;19(3):343-51.

Dolmans MM, von Wolff M, Poirot C, Diaz-Garcia C, Cacciottola L, Boissel N, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021;115(5):1102-15.

Xie B, Li J, Huang Y, Hang F, Hu Q, Yu J, et al. Assessing the impact of transplant site on ovarian tissue transplantation: a single-arm meta-analysis. Reprod Biol Endocrinol. 2023;21(1):120.

Erden M, Uyanik E, Demeestere I, Oktay KH. Perinatal outcomes of pregnancies following autologous cryopreserved ovarian tissue transplantation: a systematic review with pooled analysis. Am J Obstet Gynecol. 2024;231(5):480-9.

Jadoul P, Guilmain A, Squifflet J, Luyckx M, Votino R, Wyns C, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod. 2017;32(5):1046-54.

Hoekman EJ, Louwe LA, Rooijers M, van der Westerlaken LAJ, Klijn NF, Pilgram GSK, et al. Ovarian tissue cryopreservation: Low usage rates and high live-birth rate after transplantation. Acta Obstet Gynecol Scand. 2020;99(2):213-21.

Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908-14.

Greve T, Clasen-Linde E, Andersen MT, Andersen MK, Sørensen SD, Rosendahl M, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120(22):4311-6.

Jahnukainen K, Tinkanen H, Wikström A, Dunkel L, Saarinen-Pihkala UM, Mäkinen S, et al. Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation. Leukemia. 2013;27(5):1183-5.

Sönmezer M, Şükür YE, Saçıntı KG, Özkavukçu S, Kankaya D, Atabekoğlu CS, et al. Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: a case series. American Journal of Obstetrics and Gynecology. 2024;230(1):79. e1-. e10.

Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. Journal of Clinical Oncology. 2018;36(19):1994-2001.

Leonard RCF, Adamson DJA, Bertelli G, Mansi J, Yellowlees A, Dunlop J, et al. GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial. Ann Oncol. 2017;28(8):1811-6.

Turan V, Bedoschi G, Rodriguez-Wallberg K, Sonmezer M, Pacheco FS, Oktem O, et al. Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods. J Clin Oncol. 2019;37(1):84-6.

Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, et al. No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial. J Clin Oncol. 2016;34(22):2568-74.

Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2018;36(19):1981-90.

Preservation TEGGoFF, Anderson RA, Amant F, Braat D, D'Angelo A, Chuva de Sousa Lopes SM, et al. ESHRE guideline: female fertility preservation†. Human Reproduction Open. 2020;2020(4).

Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertility and sterility. 2010;93(3):762-8.

Sonmezer M, Oktay K. Fertility preservation in female patients. Human Reproduction Update. 2004;10(3):251-66.

Wallace WHB, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. International Journal of Radiation Oncology* Biology* Physics. 2005;62(3):738-44.

Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T. Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. Journal of ovarian research. 2014;7:1-10.

Tessier L, McKechnie T, Lee Y, Park LJ, Gangam N, Eskicioglu C. Laparoscopic ovarian transposition prior to pelvic radiation in young women with anorectal malignancies: a systematic review and meta-analysis of prevalence. Colorectal Dis. 2023;25(7):1336-48.

Gabriel DA, Bernard SA, Lambert J, Croom RD. Oophoropexy and the management of Hodgkin's disease: A reevaluation of the risks and benefits. Archives of Surgery. 1986;121(9):1083-5.

Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertility and sterility. 2000;74(4):743-8.

Genovese F, Zambrotta E, Incognito GG, Gulino FA, Di Guardo F, Genovese D, et al. Techniques and endocrine-reproductive outcomes of ovarian transposition prior to pelvic radiotherapy in both gynecologic and non-gynecologic cancers: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2024;165(3):948-58.

Huber D, Simonson C, Fournier I, Dischl-Antonioni I, Pena Rios FJ, Francey I, et al. Utero-ovarian transposition before pelvic radiation in a patient with rectal cancer: a case report and systemic literature review. Front Surg. 2024;11:1336047.

Gilchrist RB, Ho TM, De Vos M, Sanchez F, Romero S, Ledger WL, et al. A fresh start for IVM: capacitating the oocyte for development using pre-IVM. Human Reproduction Update. 2024;30(1):3-25.

Isachenko E, Rahimi G, Isachenko V, Nawroth F. In-vitro maturation of germinal-vesicle oocytes and cryopreservation in metaphase I/II: a possible additional option to preserve fertility during ovarian tissue cryopreservation. Reproductive BioMedicine Online. 2004;8(5):553-7.

Sermondade N, Sonigo C, Sifer C, Valtat S, Ziol M, Eustache F, et al. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation. Fertility and sterility. 2019;111(2):357-62.

Sauerbrun-Cutler M-T, Vega M, Keltz M, McGovern PG. In vitro maturation and its role in clinical assisted reproductive technology. Obstetrical & gynecological survey. 2015;70(1):45-57.

Creux H, Monnier P, Son W-Y, Buckett W. Thirteen years’ experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments. Journal of assisted reproduction and genetics. 2018;35:583-92.

Bourg M, Moreau J, Carles M, Cadoret F, Lesourd F, Tournier A, et al. Is in vitro maturation of oocytes retrieved ex vivo from ovarian tissue an effective fertility preservation technique in the presence of organic ovarian cysts? European Journal of Obstetrics & Gynecology and Reproductive Biology. 2023;281:87-91.

Meltem S, Ali G, Şükür YE, Hande T, Ebru A, Betül A, et al. Safety and effectiveness of controlled ovarian stimulation and oocyte retrieval during prepubertal and peripubertal period. J Assist Reprod Genet. 2024;41(10):2823-30.

Sönmezer M, Saçıntı KG, Gülümser Ç, Özkavukçu S, Atabekoğlu C, Şükür YE, et al. Transabdominal ultrasound-guided oocyte retrieval for oocyte cryopreservation using a vaginal probe: a comparison of applicability, effectiveness, and safety with conventional transvaginal approach. J Assist Reprod Genet. 2023;40(2):399-405.

Ombelet W, Van Robays J. Artificial insemination history: hurdles and milestones. Facts, views & vision in ObGyn. 2015;7(2):137.

Miller CM, Duong S, Weaver AL, Zhao Y, Shenoy CC. Outcomes of frozen oocyte donor in vitro fertilization (IVF) cycles using fresh versus frozen sperm. Reproductive Sciences. 2022;29(4):1226-31.

Hallak J, Kolettis PN, Sekhon VS, Thomas AJ, Agarwal A. Sperm cryopreservation in patients with testicular cancer. Urology. 1999;54(5):894-9.

Asseler JD, de Nie I, van Rooij FB, Steensma TD, Mosterd D, Verhoeven MO, et al. Transgender persons' view on previous fertility decision-making and current infertility: a qualitative study. Hum Reprod. 2024;39(9):2032-42.

Riggs DW, Bartholomaeus C. Fertility preservation decision making amongst Australian transgender and non-binary adults. Reprod Health. 2018;15(1):181.

De Roo C, Lierman S, Tilleman K, Peynshaert K, Braeckmans K, Caanen M, et al. Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment. Reprod Biomed Online. 2017;34(6):557-66.

Ghofranian A, Estevez SL, Gellman C, Gounko D, Lee JA, Thornton K, et al. Fertility treatment outcomes in transgender men with a history of testosterone therapy. F S Rep. 2023;4(4):367-74.

Mattelin E, Strandell A, Bryman I. Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013–2018. Human reproduction open. 2022;2022(2):hoac008.